A ranking of the leading medical tourism nations placed four Asian countries at the top, Travel Daily Media reported, in a piece that tied the region’s lead to its uptake of digital tools. The ranking, published by Nomad Capitalist in May 2025, put Malaysia first, followed by Singapore, Thailand and India, Travel Daily Media reported. Nomad Capitalist is a wealth-migration advisory rather than a health-data body, and the list is best read as one such ranking rather than an audit of patient numbers.

Asia at the top of the list

The remaining places went to Turkey, the Czech Republic, Costa Rica, Panama, Mexico and Brazil, Travel Daily Media reported. Malaysia’s position is the least surprising, the report said, given a run of growth through the pandemic and a pricing structure that undercuts many rivals across consultations, medicines and surgery. A 2020 report from Singapore Business Review, cited by Travel Daily Media, put competitive pricing at the centre of Malaysia’s appeal.

Malaysia’s draw also runs on culture. Travel Daily Media reported that its Muslim-majority make-up has positioned it for patients from West Asia and North Africa, with halal-standard healthcare products and dedicated prayer and ablution facilities inside hospitals and clinics. Those are the concrete features that move patients, and they sit beneath the ranking’s headline more usefully than the ranking itself.

The technology under the label

The trade press has taken to calling the shift “Medical Tourism 2.0,” a term Travel Daily Media attributed to GoMedii Technologies, describing a patient journey run through technology from first consultation to follow-up. The label is a vendor’s, and the useful question is which of its parts already work rather than which are promised.

Some already work. In Malaysia, Singapore and Thailand, virtual platforms such as Doctor Anywhere and Teleme now handle first consultations and booking remotely, Travel Daily Media reported, and the same systems support remote monitoring so doctors can adjust treatment plans without the patient in the room. That lowers the first barrier to cross-border care, which is getting a qualified opinion before booking a flight.

Others are further off. Travel Daily Media reported that generative and predictive artificial intelligence tools are being used to sharpen diagnoses, and that blockchain, valued for its immutable, tamper-resistant ledger, is being applied to secure patient records and cross-border payments. Those claims are harder to measure than a telemedicine booking, and they belong in the promised column until a hospital reports what they changed. Robotics is the clearer case, the report said, with China, Saudi Arabia and the Philippines drawing patients for robot-assisted surgery and physical therapy.

Marketing narrative versus measurable capability

There is a standing gap in this trade between the story a destination tells and the care a patient can actually use. A ranking published by a migration consultancy, a “2.0” label coined by a platform company and a list of technologies still being trialled all sit on the narrative side. The telemedicine platforms already taking bookings, the halal facilities already built and the prices patients already pay sit on the working side, and it is the second list that fills wards.

Wellness is being folded into the same offer. Travel Daily Media reported that speakers at AHICE Southeast Asia 2026 pointed to hotels building restorative wellness stays and to hospital-hotel partnerships packaged for patients and the companions who travel with them. That integration is real enough, though it stretches the definition of medical tourism toward general well-being, which is where the numbers get slippery.

The broader picture matches the ranking without settling the argument. Asia-Pacific medical tourism is growing, though not everywhere equally, and the AI tools the label leans on carry both promise and risk in healthcare that a single trend piece cannot resolve.

What to watch

The list itself matters less than which of its claimed advantages hold up. Whether Malaysia keeps its lead once audited patient numbers, rather than a Nomad ranking, are compared is the first thing to watch. Whether the AI and blockchain tools named here show up in a hospital’s reported outcomes is the second. Whether the telemedicine platforms already in use widen from consultation into paid treatment planning is the third, and it is the part of “Medical Tourism 2.0” doing measurable work today.